Details of the Drug

General Information of Drug (ID: DM1ASTU)

Drug Name

BI-661051

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Phase 1	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	ClinicalTrials.gov (NCT01343719) Single Rising Dose Study to Assess Safety, Tolerability and Pharmacokinetics of BI 661051.. U.S. National Institutes of Health.